EAN News

Our authors of the month conducted this study in which COVID-19 patients with neurological symptoms and cognitive impairments, underwent DMI in the subacute stage of the disease.

During the EAN 2022 Congress, EAN Scientific Committee Chair, Prof. Thomas Berger took the opportunity to chat with Prof. Wolfgang Grisold, President of the World Federation of Neurology.

One of the goals of the EAN Guideline Production Group (GPG) is to educate EAN members on the process of guideline development. This year, one day prior to the EAN Congress 2022, we held a workshop on guidelines, aiming to familiarise clinicians with the methodology behind guidelines.

Migraine—with and without aura—is one of the most common neurological disorders, affecting millions worldwide. In the past few years, several new studies have been finished and we have got a better insight into the pathophysiology of migraine.

A Regional Teaching Course organised by the EAN and the Walton Centre NHS Foundation Trust took place in Liverpool, UK on 24-26 April, 2022.

The session ‘The relevance of gender and diversity in neurology: Why should I care’ took place in Room Budapest and was moderated by EAN Board Member, Prof. Elene Moro.

This interesting symposium, titled 'Coma - what's new?' exposed the landscape of coma and disorders of consciousness regarding clinical, biological and therapeutic aspects.

The European Brain Council marked its 20th anniversary with a Special Session on 20 Years of Advocacy for the Brain at the 8th Congress of the European Academy of Neurology in Vienna on 28 June 2022.

The last day of EAN 2022 started with this interesting symposium on cognitive deficit and dementia, organised in cooperation with Alzheimer Europe.

This Special Session on Clinical, Digital and Rural facets of neurology practice was held in collaboration with the Indian Academy of Neurology.

This Special Time Zone Session on Latin American Dementia' s Perspective was organised in collaboration with the Panamerican Federation of Neurological Societies.

This very interesting Special Session in cooperation with the European Psychiatric Association covered recent progress made in Alzheimer’s disease and frontotemporal dementia, including evolving disease definitions, treatment, and prevention.

This joint Special Session between EAN and the World Federation of Neurology (WFN) was a follow-up of the European Brain Health Summit, which took place on 31 May, 2022.

This very interesting Topical Symposium provided a comprehensive summary of myasthenia gravis, including the clinical presentation, diagnostics, and well-established treatment approaches.

Plenary Symposium 3 at EAN 2022 took place in the Main Auditorium and bore the title 'Improving lives and reducing burden: what evidence do we need to implement?'